JP2018511616A5 - - Google Patents

Download PDF

Info

Publication number
JP2018511616A5
JP2018511616A5 JP2017553122A JP2017553122A JP2018511616A5 JP 2018511616 A5 JP2018511616 A5 JP 2018511616A5 JP 2017553122 A JP2017553122 A JP 2017553122A JP 2017553122 A JP2017553122 A JP 2017553122A JP 2018511616 A5 JP2018511616 A5 JP 2018511616A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
compound according
unsubstituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017553122A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018511616A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/027549 external-priority patent/WO2016168472A1/en
Publication of JP2018511616A publication Critical patent/JP2018511616A/ja
Publication of JP2018511616A5 publication Critical patent/JP2018511616A5/ja
Pending legal-status Critical Current

Links

JP2017553122A 2015-04-14 2016-04-14 短鎖デヒドロゲナーゼ活性を調節する組成物および方法 Pending JP2018511616A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562147305P 2015-04-14 2015-04-14
US62/147,305 2015-04-14
PCT/US2016/027549 WO2016168472A1 (en) 2015-04-14 2016-04-14 Compositions and methods of modulating short-chain dehydrogenase activity

Publications (2)

Publication Number Publication Date
JP2018511616A JP2018511616A (ja) 2018-04-26
JP2018511616A5 true JP2018511616A5 (cg-RX-API-DMAC7.html) 2019-05-30

Family

ID=57127188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017553122A Pending JP2018511616A (ja) 2015-04-14 2016-04-14 短鎖デヒドロゲナーゼ活性を調節する組成物および方法

Country Status (8)

Country Link
US (4) US20180118756A1 (cg-RX-API-DMAC7.html)
EP (1) EP3283074A4 (cg-RX-API-DMAC7.html)
JP (1) JP2018511616A (cg-RX-API-DMAC7.html)
CN (1) CN108012528A (cg-RX-API-DMAC7.html)
AU (1) AU2016248080A1 (cg-RX-API-DMAC7.html)
CA (1) CA2982784A1 (cg-RX-API-DMAC7.html)
HK (1) HK1250651A1 (cg-RX-API-DMAC7.html)
WO (1) WO2016168472A1 (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
US11718589B2 (en) 2017-02-06 2023-08-08 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase
US12336982B2 (en) 2018-11-21 2025-06-24 Rodeo Therapeutics Corporation Compositions and methods of modulating short-chain dehydrogenase activity
US12616681B2 (en) 2019-04-04 2026-05-05 Case Western Reserve University Compositions and methods for treating renal injury

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801863B2 (en) 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
CA2870666A1 (en) 2012-04-16 2013-10-24 Case Western Reserve University Compositions and methods of modulating 15-pgdh activity
WO2016144958A1 (en) 2015-03-08 2016-09-15 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating fibrosis
CA2927730A1 (en) 2013-10-15 2015-05-07 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
CA3031091A1 (en) * 2016-07-18 2018-01-25 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting nerve cell death
JP7178360B2 (ja) * 2017-04-07 2022-11-25 ケース ウエスタン リザーブ ユニバーシティ 冠状動脈障害を治療するための短鎖型デヒドロゲナーゼ活性の阻害剤
EP3781154A4 (en) * 2018-04-04 2022-02-23 Case Western Reserve University COMPOSITIONS AND METHODS FOR TREATMENT OF KIDNEY INJURY
JP7575952B2 (ja) 2019-01-08 2024-10-30 杏林製薬株式会社 15-pgdh阻害薬
WO2020160151A1 (en) 2019-01-31 2020-08-06 Kyorin Pharmaceutical Co., Ltd. 15-pgdh inhibitors
GB2599292A (en) * 2019-06-11 2022-03-30 Univ Leland Stanford Junior Methods of rejuvenating aged tissue by inhibiting 15-hydroxyprostaglandin dehydrogenase (15-PGDH)
CR20220654A (es) 2020-05-20 2023-08-24 Rodeo Therapeutics Corp Composiciones y métodos para modular la actividad de deshidrogenasas de cadena corta
CN117377668A (zh) * 2020-10-15 2024-01-09 迈欧伏特治疗公司 Pgdh抑制剂的吸入制剂及其使用方法
US20240000758A1 (en) * 2020-10-23 2024-01-04 The Board Of Trustees Of The Leland Stanford Junior University Elevation of mitochondrial biogenesis and function by inhibition of prostaglandin degrading enzyme 15-pgdh
JP2023552832A (ja) * 2020-12-09 2023-12-19 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 関節の構造および機能を改善するためのプロスタグランジン分解酵素15-pgdhの阻害法
CA3243368A1 (en) * 2022-01-28 2025-01-16 Scinnohub Pharmaceutical Co., Ltd. COMPOUND FOR REGULATING AND CONTROLLING THE ACTIVITY OF 15-PGDH AND ITS PREPARATION PROCESS
US20250250283A1 (en) * 2022-04-13 2025-08-07 Scinnohub Pharmaceutical Co., Ltd. Compound capable of regulating and controlling activity of 15-pgdh, and preparation method therefor
WO2024099429A1 (zh) * 2022-11-11 2024-05-16 赛诺哈勃药业(成都)有限公司 一种调控15-pgdh活性的化合物及其制备方法
TW202434597A (zh) * 2022-11-14 2024-09-01 大陸商武漢人福創新藥物研發中心有限公司 抑制15-pgdh的化合物及其用途
TW202446380A (zh) * 2023-05-19 2024-12-01 大陸商成都倍特藥業股份有限公司 一種調控15-pgdh活性的化合物、包含其的藥物組合物及它們的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904672A (en) * 1987-01-30 1990-02-27 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
GEP20053675B (en) * 2001-03-30 2005-11-25 Pfizer Prod Inc Pyridazinone Aldose Reductase Inhibitors
ATE375349T1 (de) * 2002-08-02 2007-10-15 Merck & Co Inc Substituierte furo(2,3-b)pyridin derivate
EP1781289A1 (en) * 2004-07-22 2007-05-09 PTC Therapeutics, Inc. Thienopyridines for treating hepatitis c
AU2007243466B2 (en) * 2006-04-26 2012-01-19 F. Hoffmann-La Roche Ag Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
US20100093764A1 (en) * 2008-10-13 2010-04-15 Devraj Chakravarty AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
EP2383263B1 (en) * 2008-12-30 2014-04-16 Industry-academic Cooperation Foundation, Chosun University Novel thiazolidinedione derivative and use thereof
WO2016144958A1 (en) * 2015-03-08 2016-09-15 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating fibrosis
US9801863B2 (en) * 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
CA2870666A1 (en) * 2012-04-16 2013-10-24 Case Western Reserve University Compositions and methods of modulating 15-pgdh activity
CA2927730A1 (en) * 2013-10-15 2015-05-07 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
JP2019078488A (ja) * 2017-10-25 2019-05-23 ダイキン工業株式会社 空気調和装置

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
US11718589B2 (en) 2017-02-06 2023-08-08 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase
US12336982B2 (en) 2018-11-21 2025-06-24 Rodeo Therapeutics Corporation Compositions and methods of modulating short-chain dehydrogenase activity
US12616681B2 (en) 2019-04-04 2026-05-05 Case Western Reserve University Compositions and methods for treating renal injury

Similar Documents

Publication Publication Date Title
JP2020514323A5 (cg-RX-API-DMAC7.html)
AR059009A1 (es) 2 - (poli - arilo sustituido) - 6 - amino - 5 - halo - 4 - acidos pirimidinacarboxilico, su uso como herbicida en composiciones que lo contienen y en metodos para controlar la vegetacion no deseada.
JP2017517508A5 (cg-RX-API-DMAC7.html)
JP2006502247A5 (cg-RX-API-DMAC7.html)
JP2008533191A5 (cg-RX-API-DMAC7.html)
WO2006098918B1 (en) Substituted gamma lactams as therapeutic agents
WO2008042240A3 (en) Enantiomerically pure phosphoindoles as hiv inhibitors
NZ593030A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
WO2009013299A3 (de) Neue bradykinin b1-antagonisten
MX2009009492A (es) Compuestos organicos biciclicos adecuados para el tratamiento de condiciones inflamatorias o alergicas.
RU2010139644A (ru) Ингибитор фиброза
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
EP2292590A3 (en) Prodrugs of 9-aminomethyl tetracycline compounds
JP2012526082A5 (cg-RX-API-DMAC7.html)
EP2207062A3 (en) Photosensitive compositions, curable compositions, novel compounds, photopolymerizable compositions, color filters, and planographic printing plate precursors
JP2018530582A5 (cg-RX-API-DMAC7.html)
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
JP2012526820A5 (cg-RX-API-DMAC7.html)
SI2718293T1 (en) SUBSTITUTED PYRIDOPIRAZINS AS NEW INHIBITORS OF VRANIC TYROSIN KINASE (SYK)
JP2010504286A5 (cg-RX-API-DMAC7.html)
ME02472B (me) Nitrogenovano heterociklično jedinjenje i poljoprivredni ili hortikulturni fungicid
RU2013139313A (ru) 6-амино-2-замещенные-5- винилсилилпиримидин-4-карбоновые кислоты и сложные эфиры и 4-амино-6-замещенные-3-винилсилилпиридин-пиколиновые кислоты и сложные эфиры как гербициды
CA2728098A1 (en) Pyrazole-containing tricyclic compounds as_antagonits of an ep1 receptor
EP2308828A3 (en) CaSR antagonist
PE20121280A1 (es) Derivados de (tio)morfolina como moduladores de s1p